Tilray(US:TLRY) ZACKSยท2025-09-30 23:15Company Performance - Tilray Brands, Inc. (TLRY) experienced a decline of 6.49% to $1.73 in the latest trading session, underperforming the S&P 500's daily gain of 0.41% [1] - Over the past month, shares of Tilray have increased by 34.06%, while the Medical sector has decreased by 0.38% and the S&P 500 has gained 3.15% [1] Upcoming Earnings Report - The company is set to release its earnings report on October 9, 2025, with projected earnings per share (EPS) of -$0.03, reflecting a 25% increase from the same quarter last year [2] - Revenue is estimated to be $206.83 million, indicating a 3.39% increase compared to the same quarter of the previous year [2] Fiscal Year Projections - For the entire fiscal year, the Zacks Consensus Estimates project an EPS of -$0.11 and revenue of $877.28 million, representing changes of -1200% and +6.81% respectively from the prior year [3] Analyst Estimates and Trends - Recent changes to analyst estimates for Tilray Brands should be noted, as upward revisions indicate analysts' positivity towards the company's business operations [4] - The Zacks Rank system, which assesses estimate changes, currently ranks Tilray Brands at 3 (Hold), with the consensus EPS estimate remaining stagnant over the past month [6] Industry Context - The Medical - Products industry, which includes Tilray, has a Zacks Industry Rank of 78, placing it in the top 32% of over 250 industries [7] - Research indicates that the top 50% rated industries outperform the bottom half by a factor of 2 to 1 [7]